Efecto de las variantes de CYP2C9 sobre la dosis de losartán en hipertensos chilenos
Background Losartan is widely used in many clinicals settings. Its dosage is related to the genetic characteristics of CYP2C9 enzymatic activity, which metabolizes losartan to its active form E-3174, responsible for the antihypertensive effect. Aims To identify the frequency of allelic variants CY...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Langue: | Spanish / Castilian |
| Publié: |
Sociedad Médica de Santiago
2019
|
| Sujets: | |
| Accès en ligne: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872019001201527 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|